HGF and lung carcinoma: Platelet-derived EVs enhanced tumor progression and angiogenesis in a mouse lung cancer model, through the upregulation of factors associated with tumor vascularisation, such as IL-8, VEGF, and HGF (hepatocyte growth factor) (Janowska-Wieczorek et al., 2005).